Medtronic’s GI revenue reached $671 million, while renal care solutions revenue decreased low-double digits, according to the report.
Medtronic’s organic GI revenue also decreased by 11 percent. Medtronic’s overall revenue decreased 3 percent to $7.6 billion worldwide.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
